MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
CREST Achieves Major Milestone
An update of new data regarding asymptomatic participants.
By Jamie Roberts, BSH, CCRP; Susan Hughes, BSN; MeeLee Tom, MS; Jason Avery, MPH; Alice Sheffet, PhD; Thomas G. Brott, MD; and Robert Hobson, MD
Impact of the CREST Trial
When is the right time to subject a new interventional technique to a rigorous, prospective, randomized comparison to an accepted therapy?
An Interview With Enrico Ascher, MD
The current president of the ISVS discusses the society's goals, his research interests, and improving results for the academic surgical community.
Pixel Distribution Analysis to Identify Unstable Carotid Plaques
Is carotid plaque morphology ready for prime time?
By Brajesh K. Lal, MD, and Robert W. Hobson II, MD
CREST Update
Meeting the challenges of a randomized clinical trial.
By Susan E. Hughes, BSN; MeeLee Tom, MS; Mary E. Longbottom, BA; Alice J. Sheffet, PhD; Thomas G. Brott, MD; and Robert W. Hobson II, MD
An Interview with Kenneth Rosenfield, MD
An expert asserts the importance of trials and registries, reflecting on lessons learned from his own experience, and discusses this year's VIVA meeting.
The International Society for Vascular Surgery
The ISVS was created to promote vascular surgery and to educate others about the need for a dedicated vascular surgery specialty.
By Pauline T. Mayer
LAUNCHING A NATIONAL VASCULAR EFFORT: ONE STEP AT A TIME
Sponsored by Silk Road Medical
The Evidence Base Dictating Practice in Patients With Concomitant Significant Coronary Artery and Carotid Artery Disease
By Sumaira Macdonald, MD, PhD, MBChB, MRCP, FRCP, FRCR; Richard P. Cambria, MD; and Douglas Massop, MD
CREST-2: Guiding Treatments for Asymptomatic Carotid Disease
Examining stenting and endarterectomy in the context of intensive medical management.
By Brajesh K. Lal, MD; James F. Meschia, MD; and Thomas G. Brott, MD
Thoracic Aortic Aneurysms: At What Size Should We Intervene?
Key factors to consider when selecting patients for TAA repair.
By Robert J. Hinchliffe, MD, FRCS, and Paul Hollering
